MedTrace Logo

Plasma Glucose Levels With Dexamethasone as Adjuvant to Interscalene Block

NCT01538459 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2013-05-20

No results posted yet for this study

Summary

The purpose of this study is to determine the Finger Blood Glucose (sugar) when dexamethasone is added to a local anesthetic for a shoulder nerve block procedure. The investigators hypothesize that there is no increase in plasma glucose when 8 mg of dexamethasone is used as an adjuvant with local anesthetic to interscalene regional anesthesia. By performing finger stick blood glucose measures pre/peri and post operatively the investigators will be able to determine if any such increase exists.

Conditions

  • Shoulder Pain
  • Injury of Shoulder Region
  • Disorder of Shoulder
  • Disorder of Rotator Cuff
  • Disorder of Tendon of Biceps

Interventions

DRUG

Dexamethasone

8mg (2cc 4mg/cc Solution) mixed with 20 cc 0.25% bupivacaine in one syringe resulting in 364 µgm/cc for injection in perineural space. One time dose during nerve block preoperatively.

DRUG

Bupivacaine

Control Group receives 20 cc 0.25% bupivacaine without any adjuvants

Sponsors & Collaborators

  • United States Naval Medical Center, Portsmouth

    collaborator FED

  • Lifespan

    lead OTHER

Principal Investigators

  • Geoffrey W Wilson, M.D. · United States Navy

  • Raul Masing, M.D. · Lifespan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538459 on ClinicalTrials.gov